Healthcare provider profile · identity verified

Douglas C Coltman, MD

Internal Medicine · TYLER, TX · NPI 1619940442

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	563	144
Atorvastatin Calcium	Atorvastatin Calcium	483	136
Levothyroxine Sodium	Levothyroxine Sodium	429	105
Losartan Potassium	Losartan Potassium	387	110
Pantoprazole Sodium	Pantoprazole Sodium	371	109
Amlodipine Besylate	Amlodipine Besylate	328	90
Temazepam	Temazepam	247	37
Hydrochlorothiazide	Hydrochlorothiazide	240	73
Alprazolam	Alprazolam	221	44
Potassium Chloride	Potassium Chloride	218	59
Lisinopril	Lisinopril	209	51
Gabapentin	Gabapentin	208	48
Metoprolol Succinate	Metoprolol Succinate	200	57
Tramadol Hcl	Tramadol Hcl	199	50
Escitalopram Oxalate	Escitalopram Oxalate	198	48
Tamsulosin Hcl	Tamsulosin Hcl	198	51
Metformin Hcl	Metformin Hcl	190	49
Omeprazole	Omeprazole	185	51
Bupropion Xl	Bupropion Hcl	184	42
Meloxicam	Meloxicam	183	50
Simvastatin	Simvastatin	154	45
Eliquis	Apixaban	146	26
Hydralazine Hcl	Hydralazine Hcl	146	22
Furosemide	Furosemide	138	42
Zolpidem Tartrate	Zolpidem Tartrate	135	34
Duloxetine Hcl	Duloxetine Hcl	126	24
Ezetimibe	Ezetimibe	115	24
Metoprolol Tartrate	Metoprolol Tartrate	112	32
Clopidogrel	Clopidogrel Bisulfate	109	23
Ozempic	Semaglutide	109	17
Donepezil Hcl	Donepezil Hcl	106	25
Allopurinol	Allopurinol	100	26
Synthroid	Levothyroxine Sodium	97	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	91	25
Glipizide Er	Glipizide	88	23
Pregabalin	Pregabalin	87	20
Benazepril Hcl	Benazepril Hcl	80	24
Fenofibrate	Fenofibrate Nanocrystallized	80	19
Sertraline Hcl	Sertraline Hcl	80	21
Carvedilol	Carvedilol	78	23
Xarelto	Rivaroxaban	77	16
Citalopram Hbr	Citalopram Hydrobromide	74	19
Montelukast Sodium	Montelukast Sodium	72	22
Atenolol	Atenolol	69	18
Trazodone Hcl	Trazodone Hcl	69	15
Ipratropium Bromide	Ipratropium Bromide	67	20
Albuterol Sulfate Hfa	Albuterol Sulfate	66	32
Eszopiclone	Eszopiclone	66	16
Fluoxetine Hcl	Fluoxetine Hcl	63	14
Venlafaxine Hcl Er	Venlafaxine Hcl	58	14
Fluticasone Propionate	Fluticasone Propionate	57	25
Prednisone	Prednisone	57	19
Solifenacin Succinate	Solifenacin Succinate	57	suppressed
Buspirone Hcl	Buspirone Hcl	56	16
Cephalexin	Cephalexin	56	38
Esomeprazole Magnesium	Esomeprazole Magnesium	56	13
Methylprednisolone	Methylprednisolone	54	47
Alendronate Sodium	Alendronate Sodium	53	14
Acetaminophen-Codeine	Acetaminophen With Codeine	45	18
Clonazepam	Clonazepam	44	suppressed
Lorazepam	Lorazepam	44	suppressed
Pravastatin Sodium	Pravastatin Sodium	42	13
Chlorthalidone	Chlorthalidone	39	suppressed
Raloxifene Hcl	Raloxifene Hcl	39	suppressed
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	39	35
Pioglitazone Hcl	Pioglitazone Hcl	38	14
Rasagiline Mesylate	Rasagiline Mesylate	38	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	33
Finasteride	Finasteride	37	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	37	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	17
Amoxicillin	Amoxicillin	35	32
Oxybutynin Chloride Er	Oxybutynin Chloride	34	11
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Memantine Hcl	Memantine Hcl	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	11
Triamcinolone Acetonide	Triamcinolone Acetonide	30	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	15
Celecoxib	Celecoxib	28	12
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Testosterone Cypionate	Testosterone Cypionate	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	17
Estradiol	Estradiol	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Mounjaro	Tirzepatide	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Alprazolam Er	Alprazolam	25	suppressed
Aripiprazole	Aripiprazole	25	suppressed
Latanoprost	Latanoprost	25	suppressed
Ramipril	Ramipril	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	21
Farxiga	Dapagliflozin Propanediol	24	suppressed
Irbesartan	Irbesartan	24	suppressed
Ondansetron Odt	Ondansetron	24	suppressed
Valsartan	Valsartan	24	suppressed
Rizatriptan	Rizatriptan Benzoate	23	suppressed
Glipizide	Glipizide	22	suppressed
Baclofen	Baclofen	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Primidone	Primidone	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Azithromycin	Azithromycin	18	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Fluconazole	Fluconazole	18	13
Nitroglycerin	Nitroglycerin	18	11
Telmisartan	Telmisartan	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Cefuroxime	Cefuroxime Axetil	16	16
Colchicine	Colchicine	16	suppressed
Lagevrio (Eua)	Molnupiravir	16	16
Novolog Flexpen	Insulin Aspart	16	suppressed
Anastrozole	Anastrozole	15	suppressed
Diazepam	Diazepam	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Niacin Er	Niacin	15	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	15	suppressed
Risperidone	Risperidone	15	suppressed
Torsemide	Torsemide	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Famotidine	Famotidine	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Risedronate Sodium	Risedronate Sodium	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error